scholarly journals Fibroblast growth factor 21 inhibition aggravates cardiac dysfunction in diabetic cardiomyopathy by improving lipid accumulation

Author(s):  
Cui Chen ◽  
Zheying Meng ◽  
Yuanyi Zheng ◽  
Bing Hu ◽  
E. Shen
2019 ◽  
Vol 24 (6) ◽  
pp. 1005-1017 ◽  
Author(s):  
Xiang Zhang ◽  
Luo Yang ◽  
Xiongfeng Xu ◽  
Fengjuan Tang ◽  
Peng Yi ◽  
...  

2016 ◽  
Vol 130 (8) ◽  
pp. 625-641 ◽  
Author(s):  
Jingjing Zhang ◽  
Yanli Cheng ◽  
Junlian Gu ◽  
Shudong Wang ◽  
Shanshan Zhou ◽  
...  

Fenofibrate (FF) as a commonly-used lipid-lowering medicine in clinics was examined for its potentially repurposing to prevent the cardiac abnormalities in patients with type 1 diabetes. We demonstrated here that fenofibrate significantly prevented diabetes-induced cardiac dysfunction and remodeling in fibroblast growth factor 21 (FGF21)-dependent manner.


2018 ◽  
Author(s):  
Fahim Ebrahimi ◽  
Carole Wolffenbuttel ◽  
Claudine A Blum ◽  
Beat Muller ◽  
Philipp Schuetz ◽  
...  

2019 ◽  
Author(s):  
Fahim Ebrahimi ◽  
Sandrine Urwyler ◽  
Matthias Betz ◽  
Emanuel Christ ◽  
Philipp Schuetz ◽  
...  

Author(s):  
Ewa Szczepańska ◽  
Małgorzata Gietka-Czernel ◽  
Piotr Glinicki ◽  
Helena Jastrzębska ◽  
Jadwiga Słowińska-Srzednicka ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document